Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NEOP
NEOP, bought @ 2.95 last week.. with sheff on the boat too now, doesn,t hurts at all
Thank you sir. That helps to learn biotech trading better.
well said ..thanx for reply
can anybody tell what,s up with PLX, down 1. 5 % !!!
Kei. sincel june 15th short interst is between 7.5 mil to 8.5 mil. before june 15 dcth was trading at 16 bucks. now blacrock on the board and several major catalyst on horizone i think, it should pop. i never underestimate power of shorts. but this much short is since last six months , nothing new. since last week, i think we are already seeing short covering. let,s hope for the best.
AGREE 100%
Stock Investor .. great article..throws chills through the spine when your read some of the decisions. I WAS PART OF INTERMUNE, AND ALMOST LOST MY SHIRT.. BUT I AM A FIGHTER AND LERAN FROM MY MISTAKE AND NOW I DON'T MAKE MISTAKES TO LEARN AND FORTUNATELY GOT GREAT SHEFF BOARD,.. SHEFF..WHO IS SO AWESOMELY GIFTED MAN WITH THESE PLAY.. JUST AWESOME.
"LERAN FROM YOUR MISTAKES, DON'T MAKE MISTAKES TO LEARN"
ronpopeil...Coz they heard that i am also accumulating DCTH LOL
dcth.. 10.75 HOD
dcth, WILL GET PRIORITY REVIEW FOR SURE..GREAT RESULTS IN CANCER PATIENTS, WHY NOT IT WILL GET PRIORITY REVIEW. GREAT COMPANY WITH GREAT php TECHNOLOGY
ronpopeil, dr stock alert DCTH , the bigger news are probably, phase 2 result for hepatic tumor and publication of phase III results in a prestigious journal. i think we will see it soon rising in the sky.. well may be..
ronpopeil.. bought 6000 dcth yesterday
Stock HOG ..great read
ronpopeil, great info
PLX..Sheff. Great read and insight. agree 100%
Started position in delcath @ 10.08, one of fav, with amrn and plx.
Sinyan...very intersting story. Thanks for sharing . Million dollar learing experience in one page..price less, will read it again.
i lost fortune in ITMN and ALXA, still in negetive, but wounds are healing back slowly with depo and AVNR.
Sheff, investor 100 and BFR are very humble human being and this board is helping people like us to slowly getting back to even.
May god bless them!!!! truly !
TIM... you too!!!
Investor 100, sheff, BFR... hates up to you guys , thanks a lot, great job you all..just one of the best biotech resource on the planet for biotechs
Thanks a lot
investor 100, any target on depo price, any idea how to trade. reply will be appreciated.
i will be on cc of depo . will try to put up very important points
Appreciate it sir
DCTH: ADAM F thinks its not great stuff. why i think 180 degree opposite.
I think it should be game changer the way you treat melanoma mets.
Can some body ask adam big..., is there any effective therapy for metastatic melanoma, answer is no.
PHP reduces the tumor burden in the liver( one of the most common organ in metastatic disease which shortens the life span and quality of life) without infusing large quantity in the system. I mean it does infuses large quantity in the tumor but at the same time the great php system removes it out from the veins(IVC and hepatic vein). this large quantity of melphalan does dramatic effect on the the tumor per phase III and theoratically that sounds good too. can you give that large quantity without PHP. No, patient will die on table.
They are doing study in HCC also. some times advanced hcc tumor need localized therapy. I am an interventional radiologist, i do Rf ablation of tumor and chemoembolization of HCC, but if there are multiple tumor , large in size, and if trial improves survival with stastical significance, which i think it should,( time will tell) , it will be huge. in taiwan they are doing php phase one with doxrubicine, which is drug of choice for hcc.
what ever i understand it looks really promising, with bio techs you can miss important point even with all the knowledge. That's where sheff comes in to play. but i am definately looking to start some position some time.
PLX very intersting read sheff. sheff these are small articles can you go through these and comment some thing. it will be appreciated. will start plx position after selling my depo $$$$.
this guy (dr frost philip) was chairman of plx and teva also and resigned from board of plx in 2007 . sold 1.7 million shares recentely in 2011.
also in 2007 when plx was @36 $ they did a stock offering with 5 bucks.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000617866
.
http://www.accessmylibrary.com/article-1G1-170287489/protalix-biotherapeutics-stock-price.html
http://www.streetinsider.com/Management+Changes/Phillip+Frost+and+Jane+H.+Hsiao+Resign+From+Protalix+BioTherapeutics+(PLX)+Board/3175348.html
thanks Sheff
avnr, 20 M shares or $ 20 M , i am confused
OXGN does anybody knows why its running pm and AH
Barefootrunner, thanks . that was really comprehensive. you are a great asset to this board. helping small retail investors like us. keep up good work guys. I pray for all the people who maintain this board with such an honesty and dedication. it,s unreal in this world! seriously!!
CYCC, nasdaq institutional holding was 12 % before few days and now it is 9 % does that matters and what does that means. ANY REPLAY WOULD BE APPRECIATED
sheff oxgn really high in AH . what,s up with that any info
Knulp, HGSI, Very good analysis. i was doutful what to do about it. but after reading your article, i am clear that i will wait and watch, same like sheff also said.
Great Sheff! Keep up great work. May god bless you.
Tim. great info. you are a great asset to this board. thanks
agree
as you know neudexta does not cures ALS. it improves their life style significantly
cosmic school, i agree with you. clarus is venture capital. they need to manage there portfolio. did any body looked there portfolio,nearly 20-25 early stage biotech company. it make sense for them to raise money. still holding large portion to ride out profit if price doubles from here.
Cryptic we will see. please be there when that happens
i dont see every patient with ALS taking this drug. only pba patinet will take it. remember 50 % of als has PBA. for MS which is larger population, if company does promote for pain also under the table than it may see better sell. depends on how company promotes and how doctors want to precribe in MS patiets.
the bigger picture is stroke, TBI(BRain injury) Including veterens and parkinsons patients. who make the major portion of sell for neudexta. if they can penetrate these three market well, things will be very rosy for AVNR. GOD knows time will tell. but i cetainly think $ 15 target by jeffery is not a pump at all given the potential for this drug.